XML 17 R5.htm IDEA: XBRL DOCUMENT v3.19.1
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Noncontrolling Interest [Member]
Series A Preferred Stock
Preferred Stock
Series C Preferred Stock
Preferred Stock
Beginning balance (in shares) at Dec. 31, 2017   32,658,176       453,567 31,568
Beginning balance at Dec. 31, 2017 $ 28,384,358 $ 32,658 $ 67,768,509 $ (39,816,300) $ 399,005 $ 454 $ 32
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Share based compensation expense, total 145,971   145,971        
Conversion of Series B1 Preferred stock to common (in shares)   500,000          
Conversion of Series B1 Preferred stock to common 595,563 $ 500 779,500 (184,437)      
Dividends on Series B and B1 (554,917)     (554,917)      
Accretion of discount on Series B and B1 (457,853)     (457,853)      
Net income (loss) (2,208,083)     (2,258,622) 50,539    
Ending balance (in shares) at Mar. 31, 2018   33,158,176       453,567 31,568
Ending balance at Mar. 31, 2018 25,905,039 $ 33,158 68,693,980 (43,272,129) 449,544 $ 454 $ 32
Beginning balance (in shares) at Dec. 31, 2018   40,174,821       419,859  
Beginning balance at Dec. 31, 2018 28,809,044 $ 40,175 75,131,122 (47,800,886) 1,438,213 $ 420  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Share based compensation expense, total 143,063   143,063        
Conversion of Series B1 Preferred stock to common (in shares)   96,160          
Conversion of Series B1 Preferred stock to common 119,768 $ 96 149,914 (30,242)      
Dividends on Series B and B1 (406,795)     (406,795)      
Accretion of discount on Series B and B1 (530,433)     (530,433)      
Net income (loss) (5,068,995)     (4,963,564) (105,431)    
Ending balance (in shares) at Mar. 31, 2019   40,270,981       419,859  
Ending balance at Mar. 31, 2019 $ 23,065,652 $ 40,271 $ 75,424,099 $ (53,731,920) $ 1,332,782 $ 420